Sensitivity studies on Serratia strains from clinical specimens.
D000667:Ampicillin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001431:Bacteriological Techniques; D002512:Cephalothin / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D003091:Colistin / Q000494:pharmacology; D004917:Erythromycin / Q000494:pharmacology; D005664:Furazolidone / Q000494:pharmacology; D006801:Humans; D007612:Kanamycin / Q000494:pharmacology; D009268:Nalidixic Acid / Q000494:pharmacology; D009355:Neomycin / Q000494:pharmacology; D009582:Nitrofurantoin / Q000494:pharmacology; D009583:Nitrofurazone / Q000494:pharmacology; D009675:Novobiocin / Q000494:pharmacology; D010400:Penicillin G / Q000494:pharmacology; D010403:Penicillin Resistance; D012706:Serratia marcescens / Q000187:drug effects*; D013307:Streptomycin / Q000494:pharmacology; D013411:Sulfadiazine / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology; D014217:Troleandomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D013411:Sulfadiazine; D009675:Novobiocin; D009268:Nalidixic Acid; D007612:Kanamycin; D005664:Furazolidone; D004917:Erythromycin; D002701:Chloramphenicol; D000667:Ampicillin; D009582:Nitrofurantoin; D014217:Troleandomycin; D013752:Tetracycline; D009355:Neomycin; D010400:Penicillin G; D002512:Cephalothin; D009583:Nitrofurazone; D013307:Streptomycin; D003091:Colistin